Balancing Trastuzumab's Survival Benefits And Heart Risks For Women With Breast Cance

[News]

Adding trastuzumab (trade name Herceptin) to the treatment offered to women who have HER2-positive breast cancer, significantly increases the chance of life being prolonged, and reduces the chance of tumours reappearing once therapy stops...

More... (http://www.medicalnewstoday.com/releases/244226.php)